November 6, 2019Open Access

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Key Points

Key points are not available for this paper at this time.

Abstract

TAK-003 was efficacious against symptomatic dengue in countries in which the disease is endemic. (Funded by Takeda Vaccines; TIDES ClinicalTrials.gov number, NCT02747927.).

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Key Points

Abstract

Cite This Study